Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Goldblatt

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Vaccine|June 3, 2008
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaM Saaka, B J Okoko, R C Kohberger, et al.
The Journal of Hospital Infection|January 10, 2021
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countriesD Goldblatt, M Johnson, O Falup-Pecurariu, et al.
Blood|January 11, 2000
Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assemblyJ H Leusen, C Meischl, M H Eppink, et al.
Journal of Clinical Microbiology|June 2, 2000
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay studyB D Plikaytis, D Goldblatt, C E Frasch, et al.
Immunity & Ageing : I & A|June 3, 2026
Insights into the heterogeneity of pneumococcal polysaccharide vaccine immunogenicity in older adultsM Visser, Y Kuijpers, I Tcherniaeva, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2011
Establishment of a new human pneumococcal standard reference serum, 007spD Goldblatt, B D Plikaytis, M Akkoyunlu, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Vaccine|June 3, 2008
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaM Saaka, B J Okoko, R C Kohberger, et al.
The Journal of Hospital Infection|January 10, 2021
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countriesD Goldblatt, M Johnson, O Falup-Pecurariu, et al.
Blood|January 11, 2000
Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assemblyJ H Leusen, C Meischl, M H Eppink, et al.
Journal of Clinical Microbiology|June 2, 2000
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay studyB D Plikaytis, D Goldblatt, C E Frasch, et al.
Immunity & Ageing : I & A|June 3, 2026
Insights into the heterogeneity of pneumococcal polysaccharide vaccine immunogenicity in older adultsM Visser, Y Kuijpers, I Tcherniaeva, et al.
Clinical and Vaccine Immunology : CVI|August 20, 2011
Establishment of a new human pneumococcal standard reference serum, 007spD Goldblatt, B D Plikaytis, M Akkoyunlu, et al.
Pageof 18